The Institute for Clinical and Economic Review (ICER) published a report in March outlining a conceptual framework for developing a common approach to using RWE to make treatment decisions and reporting on benefits and potential drawbacks of this trend.
Open access may have helped disseminate important scientific information, but it has also led to the proliferation of predatory journals and congresses
You Don’t Know What You Don’t know is a common phrase in Pharma, however, letting data give you a full picture is one way to know what you don’t know
Safe Harbor prohibits much of the communication between commercial operations and Medical Affairs; publication planners may not be able to easily access the R&D work that has come before; regional affiliates may be presenting posters at meetings independent of headquarters. Can your organization see the full picture?
Data Really Isn’t Permanent Cyber specialists warn that once something appears on the Internet, it’s there forever. That’s probably truer for salacious photos of pop stars than it is for corporate or government data, though. In scientific communications, unless you collect data as it’s published, you may not be able to retrieve the information you want when you need it.